尼安德特人单倍型对膜性肾病具有保护作用
研究探讨了PLAZR1基因周围区域的尼安德特人单倍型与膜性肾病(MN)的关系,通过重建系统发育和比较变异分布,发现一个源自尼安德特人的105 kb单倍型在对照组中富集,提示对MN具有保护作用。
要点
- PLA2R1基因区域存在源自尼安德特人的105 kb单倍型。
- 该单倍型在膜性肾病患者中减少,在对照中富集,提示保护效应。
- 尼安德特人基因渗入可能影响膜性肾病的遗传易感性。
核心结论
- 渗入的尼安德特人单倍型与PLA2R1重叠,在膜性肾病病例和对照中的分布不同,在对照中富集提示保护作用。
研究设计与样本
- 基于既往全基因组关联研究参与者,重建尼安德特人和现代人单倍型系统发育,计算聚类概率,并比较病例与对照的尼安德特变异分布。
主要发现
- 在507 kb富含渗入序列的区域中,严格定义的105 kb单倍型与PLA2R1和ITGB6编码区相交,遗传自尼安德特人。
- 该尼安德特人单倍型在膜性肾病病例和对照中差异呈现,在对照中富集。
临床怎么用
- 提示PLA2R1区域的尼安德特人单倍型可能作为膜性肾病的保护性遗传因素,需进一步验证。
局限性
- 研究基于既往GWAS数据,未报告样本量、P值等具体数值,保护效应的机制未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Class 2 HLA and PLA2R1 alleles are exceptionally strong genetic risk factors for membranous nephropathy (MN), leading, through an unknown mechanism, to a targeted autoimmune response. Introgressed archaic haplotypes (introduced from an archaic human genome into the modern human genome) might influence phenotypes through gene dysregulation. Here, we investigated the genomic region surrounding the PLA2R1 gene. We reconstructed the phylogeny of Neanderthal and modern haplotypes in this region and calculated the probability of the observed clustering being the result of introgression or common descent. We imputed variants for the participants in our previous genome-wide association study and we compared the distribution of Neanderthal variants between MN cases and controls. The region associated with the lead MN risk locus in the PLA2R1 gene was confirmed and showed that, within a 507 kb region enriched in introgressed sequence, a stringently defined 105 kb haplotype, intersecting the coding regions for PLA2R1 and ITGB6, is inherited from Neanderthals. Thus, introgressed Neanderthal haplotypes overlapping PLA2R1 are differentially represented in MN cases and controls, with enrichment In controls suggesting a protective effect.
引用
- Voinescu CD, Mozere M, Genovese G, et al. A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy. Kidney Int. 2024. PMID: 38367960. doi:10.1016/j.kint.2024.01.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。